Flow-based assays for global assessment of hemostasis. Part 1: Biorheologic considerations

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 11, 2006, Pages 2486-2487

  Zwaginga, J J ^a   Nash, G ^b   King, M R ^c   Heemskerk, J W M ^d   Frojmovic, M ^e   Hoylaerts, M F ^f   Sakariassen, K S ^g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c University of Rochester   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g KellSa sas   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRILLAR COLLAGEN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD CLOTTING; BLOOD FLOW; BLOOD RHEOLOGY; BLOOD VESSEL WALL; BLOOD VISCOSITY; CELL SIZE; ERYTHROCYTE DEFORMABILITY; FLOW MEASUREMENT; HEMODYNAMIC PARAMETERS; HEMOSTASIS; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOSIS; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; BLOOD FLOW VELOCITY; HUMANS; RHEOLOGY; THROMBOSIS;

EID: 33750046618     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02177.x     Document Type: Article

References (12)

1. Nurden AT. Inherited abnormalities of platelets. Thromb Haemost 1999; 82: 468-80.
2. Cattaneo M. Congenital disorders of platelet secretion. In: Gresele P, Page CP, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-thrombotic Disorders. Cambridge: Cambridge University Press, 2002: 655-73.
3. Rao AK. Congenital platelet signal transduction defects. In: Gresele P, Page CR, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-thrombotic Disorders. Cambridge: Cambridge University Press, 2002: 674-88.
4. Lillicrap D, Dean J, Blanchette VS. Willebrand disease. In: Lilleyman J, Hann I, Blanchette V, eds. Pediatric Hematology, 2nd edn. London: Churchill Livingstone, 1999: 601-9.
5. Bennett JS. Acquired platelet function defects. In: Gresele P, Page CR, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-thrombotic Disorders. Cambridge: Cambridge University Press, 2002: 689-706.
6. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324: 27-39.
7. Reitsma PH. Genetic heterogeneity in hereditary thrombophilia. Haemostasis 2000; 30: 1-10.
8. Bauer KA Management of thrombophilia. J Thromb Haemost 2003; 1: 1429-34.
9. Ruggeri ZM. Platelet-vessel wall interactions in flowing blood. In: Colman RW, Hirsch J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis. Philadelphia, PA, USA: Lippincott, 2001: 683-98.
10. Jackson SP, Mistry N, Yuan YP. Platelets and the injured vessel wall: 'rolling into action'. Focus on glycoprotein Ib/V/IX and the platelet cytoskeleton. Trends Cardiovasc Med 2000; 10: 192-7.
11. Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: Basic principles and applications. Thromb Haem 1986; 55: 415-35.
12. Zwaginga JJ, Sakariassen KS, Nash G, King MR, Heemskerk JWM, Frojmovic M, Hoylaerts MF, Biorheology Subcommittee of the SSC of the ISTH. Flow-based assays for global assessment of hemostasis. Part 2: Current methods and considerations for the future. J Thromb Haemost 2006; DOI: 10.1111/j.1538-7836.2006.02178.x.